REFERENCES
References - Biomagnetic Separation
1.01
Bergemann C., Müller-Schulte D., Oster
J., Brassard L., Lübbe A.S. Magnetic ion-exchange nano-
and microparticles for medical, biochemical and molecular biological
applications. J. of Magnetism and Magnetic Materials 1999; 194: 45-52.
1.02
Sieben S., Bergemann C., Lübbe A.S.,
Brockmann B., Rescheleit D. Comparison of different
particles and methods for magnetic isolation of circulating tumor cells.
J. of Magnetism and Magnetic Materials 2001; 225: 175-179.
1.03
Liu Jing Magnetorheological
Fluids: From Basic Physics to Application JSME International Journal
Series B 2002; 45(1): 55-60.
1.04
Frenzel A., Bergemann C., Köhl G.,
Reinard T. Novel purification system for 6xHis-tagged
proteins by magnetic affinity separation. J. Chromatography B 2003; 793:
325-329.
1.05
Deponte S., Steingroewer J., Löser C.,
Boschke E. and Bley T. Biomagnetic separation of
Escherichia coli by use of anion-exchange beads: measurement and
modeling of the kinetics of cell-bead interactions. Anal. Bioanal. Chem.
2004; 379: 419-426.
1.06
Villanueva J., Philip J., Entenberg D.,
Chaparro C. A., Tanwar M. K., Holland E. C. and Tempst P. Serum
Peptide Profiling by Magnetic Particle-Assisted, Automated Sample
Processing and MALDI-TOF Mass Spectrometry. Anal. Chem. 2004; 76:
1560-1570.
1.07
Zhang X., Sau-Mei Leung, Claudia R. Morris and Mark K. Shigenaga
Evaluation of a Novel, Integrated Approach Using Functionalized Magnetic Beads, Bench-Top
MALDI-TOF-MS with Prestructured Sample Supports, and Pattern Recognition Software for
Profiling Potential Biomarkers in Human Plasma.
Journal of Biomolecular Techniques 2004; 15(3): 167-157.
1.08
Baumann S., Uta Ceglarek, Georg Martin Fiedler, Jan Lembcke,
Alexander Leichtle, and Joachim Thiery Standardized Approach to Proteome
Profiling of Human Serum Based on Magnetic Bead Separation and Matrix-Assisted Laser
Desorption/Ionization Time-of-Flight Mass Spectrometry. Clinical Chemistry
2005; 51(6): 973–980.
1.09
Boschke E., Steingroewer J. und Bley T. Einsatz
der biomagnetischen Separation zur mikrobiologischen Qualitätskontrolle
von Lebensmitteln Chemie Ingenieur Technik (CIT) 2005; 77(7): 912-919.
1.10
Hillel Haim, Israel Steiner and Amos
Panet. Time Frames for Neutralization during the Human
Immunodeficiency Virus Type 1 Entry Phase, as Monitored in Synchronously
Infected Cell Cultures. J. of Virology 2005; 79 (1): 622-625.
1.11
Jörg Neumann and Ralf Brinkmann. Boiling
nucleation on melanosomes and microbeads transiently heated by
nanosecond and microsecond laser pulses. Journal of Biomedical Optics
2005; 10(2): 024001-1 - 024001-12.
1.12
Jörg Neumann and Ralf Brinkmann. Nucleation
and dynamics of bubbles forming around laser heated microabsorbers.
Therapeutic Laser Applications and Laser-Tissue Interactions II 2005;
Proc. SPIE Vol. 5863.
1.13
Villanueva J., Philip J., Chaparro C.A.,
Li Y., Toledo-Crow R., DeNoyer L., Fleisher M., Robbins R.J. and Tempst
P. Correcting Common Errors in Identifying
Cancer-Specific Serum Peptide Signatures. J. of Proteome Research 2005;
4: 1060-1072.
1.14
Berensmeier S. Magnetic
particles for the separation and purification of nucleic acids Appl
Microbiol Biotechnol (2006) 73:495–504.
1.15
Franzreb M., Siemann-Herzberg M., Hobley
T.J. and Thomas R.T. O. Protein purification using
magnetic adsorbent particles. Appl. Microbiol. Biotechnol. 2006; 70:
505–516.
1.16
Prikryl P., Horak D., Ticha M. and
Kucerova Z. Magnetic IDA-modified hydrophilic
methacrylatebased polymer microspheres for IMAC protein separation. J.
Sep. Sci. 2006;29, 2541–2549
1.17
Stratmann J., Karen Dohmann, Julia Heinzmann, and Gerald-F.
Gerlach Peptide aMpt-Mediated Capture PCR for Detection of Mycobacterium
avium subsp. paratuberculosis in Bulk Milk Samples. APPLIED AND
ENVIRONMENTAL MICROBIOLOGY 2006; 72(8): 5150–5158.
1.18
Asgar E., Büssow K., Oster J., Sieper J.,
Thiel A., Duchmann R. and Adam T. Homologous
high-throughput expression and purification of highly conserved E coli
proteins. Microbial Cell Factories 2007; 6:18. [purification of
endotoxins from protein solution]
1.19
Brizzolara R.A. and Stamper D.M. The
effect of covalent surface immobilization on the bactericidal efficacy
of a quaternary ammonium compound. Surf. Interface Anal. 2007; 39:
559–566.
1.20
Hillel Haim, Israel Steiner and Amos
Panet. Synchronized Infection of Cell Cultures by
Magnetically Controlled Virus. J. of Virology 2007; 81 (7): 3525-3534.
1.21
Issle J. and Hartmann U. Scanning
force microscopy on spatially and temporally varying magnetic substrates
for cell cultivation. Journal of Physics: Conference Series 61 (2007)
487–491.
1.22
Kettering M., Winter J., Zeisberger M.,
Bremer-Streck S., Oehring H., Bergemann C., Alexiou C., Hergt R.,
Halbhuber K.J., Kaiser W.A. and Hilger I. Magnetic
nanoparticles as bimodal tools in magnetically induced labelling and
magnetic heating of tumour cells: an in vitro study.
Nanotechnology 2007; 18: 1 – 9.
1.23
Mitchels J., Hawkins P., Luxton R. and
Rhodes A. Quantification in histopathology – Can
magnetic particles help? Journal of Magnetism and Magnetic Materials
2007; 311: 264-268.
1.24
Sellaro T. L., Ravindra A. K., Stolz D.
B. and Badylak S. Maintenance of Hepatic Sinusoidal
Endothelial Cell Phenotype In Vitro Using Organ-Specific Extracellular
Matrix Scaffolds. Tissue Engineering 2007; 13(9): 2301-2310.
1.25
Steingroewer J., Bley T., Bergemann Ch.
and Boschke E. Biomagnetic separation of Salmonella
Typhimurium with affine and specific ligand peptides isolated by phage
display technique. J. Magnetism Magnet. Materials 2007; 311: 295-299.
1.26
Stolz D. B., Ross M. A., Ikeda A.,
Tomiyama K, Kaizu T., Geller D. A. and Murase N. Sinusoidal
Endothelial Cell Repopulation Following Ischemia/Reperfusion Injury in
Rat Liver Transplantation. Hepatology 2007; 46(5): 1464-1475.
1.27
Gammerman A., Vovk V., Burford B.,
Nouretdinov I., Luo Z., Chervonenkis A., Waterfield M., Cramer R.,
Tempst P., Villanueva J., Kabir M., Camuzeaux S., Timms J., Menon U. and
Jacobs I. Serum Proteomic Abnormality Predating Screen
Detection of Ovarian Cancer. The Computer Journal Advance Access
published April 15, 2008.
1.28
Hall P. R., Hjelle B., Brown D. C., Ye
C., Bondu-Hawkins V., Kilpatrick K. A. and Larson R. S. Multivalent
Presentation of Antihantavirus Peptides on Nanoparticles Enhances
Infection Blockade. Antimicrobial Agents and Chemotherapy 2008; 52 (6):
2079–2088.
1.29
Issle J.,Mateu Pla-Roca, Elena Martinez
and Uwe Hartmann. Patterning of Magnetic Nanobeads on
Surfaces by Poly(dimethylsiloxane) Stamps. Langmuir 2008; 24: 888-893.
1.30
Jankovicova B., Rosnerova S., Slovakova
M., Zverinova Z., Hubalek M., Hernychova L., Rehulka P., Viovy J-P.,
Bilkova Z. Epitope mapping of allergen ovalbumin using
biofunctionalized magnetic beads packed in microfluidic channels The
first step towards epitope-based vaccines Journal of Chromatography A
2008; 1206: 64–71
1.31
Korecká L., Jankovicová B., Krenková J.,
Hernychová L., Slováková M., Le-Nell A., Chmelik J., Foret F., Viovy
J-L., Bilková Z. Bioaffinity magnetic reactor for
peptide digestion followed by analysis using bottom-up shotgun
proteomics strategy. J. Sep. Sci. 2008; 31: 507 – 515.
1.32
Natividad E., Castro M. and Mediano A. Accurate
measurement of the specific absorption rate using a suitable adiabatic
magnetothermal setup Appl. Phys. Lett. 2008; 92: 093116-1 — 093116-3.
1.33
Reichardt W., Dürr C., Elverfeldt D. von,
Jüttner E., Gerlach U. V., Yamada M., Smith B., Negrin R. S. and Zeiser
R. Impact of Mammalian Target of Rapamycin Inhibition
on Lymphoid Homing and Tolerogenic Function of Nanoparticle-Labeled
Dendritic Cells following Allogeneic Hematopoietic Cell Transplantation
The Journal of Immunology 2008; 181: 4770-4779.
1.34
Schaller Vincent; Kräling, Ulli; Rusu,
Cristina; Petersson, Karolina; Wipenmyr, Jan; Krozer, Anatol; Wahnström,
Göran; Sanz-Velasco, Anke; Enoksson, Peter; Johansson, Christer Motion
of nanometer sized magnetic particles in a magnetic field gradient
Journal of Applied Physics 2008;104 (9): 093918-093918-14.
1.35
Jankovicova B., Sarka Rosnerova, Marcela
Slovakova, Zuzana Zverinova, Martin Hubalek, Lenka Hernychova, Pavel Rehulka,
Jean-Louis Viovy, Zuzana Bilkova. Epitope mapping of allergen ovalbumin
using biofunctionalized magnetic beads packed in microfluidic channels The first
step towards epitope-based vaccines. Journal of Chromatography A 2008;
1206: 64–71.
1.36
Hillel Haim, Zhihai Si, Navid Madani,
Liping Wang, Joel R. Courter, Amy Princiotto, Aemro Kassa, Marciella
DeGrace, Kathleen McGee-Estrada, Megan Mefford, Dana Gabuzda, Amos B.
Smith III, Joseph Sodroski. Soluble CD4 and CD4-Mimetic
Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived
Activated State. PLoS Pathogens 2009; 5(4): 1-13.
1.37
Lewandrowski U. and Albert Sickmann. N-Glycosylation
Site Analysis of Human Platelet Proteins by Hydrazide Affinity Capturing
and LC-MS/MS. Methods in Molecular Biology, Glycomics: Methods and
Protocols 2009; 534: 225-238.
1.38
Mahowald J. Delphine Arcizet and Doris
Heinrich Impact of External Stimuli and Cell
Micro-Architecture on Intracellular Transport States ChemPhysChem 2009,
10, 1559 – 1566.
1.39
Tseng P., Dino Di Carlo and Jack W. Judy
Rapid and Dynamic Intracellular Patterning of
Cell-Internalized Magnetic Fluorescent Nanoparticles. Nano Letters 2009
Revised Manuscript Received June 18, 2009
1.40
Kottakis F., Christina Befani, Antonios
Asiminas, Maria Kontou, Georgios Koliakos and Theodora
Choli-Papadopoulou The C-terminal Region of HPNAP
Activates Neutrophils and Promotes Their Adhesion to Endothelial Cells
Helicobacter 2009,1:177–179.
1.41
Schaller Vincent, Göran Wahnström, Anke
Sanz-Velasco, Peter Enoksson and Christer Johansson Monte
Carlo simulation of magnetic multi-core nanoparticles Journal of
Magnetism and Magnetic Materials 2009; 321 (10): 1400-1403.
1.42
Schaller Vincent, Goran Wahnstrom, Anke
Sanz- Velasco, Stefan Gustafsson, Eva Olsson, Peter Enoksson, and
Christer Johansson Effective magnetic moment of
magnetic multicore nanoparticles 2009 in press.
1.43
Schaller Vincent, Anke Sanz- Velasco,
Alexey Kalabukhov, Justin F. Schneidermann, Fredrik Öisjöen, Aldo
Jesorka, Andrea Prieto Astalan, Anatol Krozer, Christina Rusu, Peter
Enoksson, and Dag Winkler Towards an
electrowetting-based digital microfluidic platform for magnetic
immunoassays 2009 in press.
1.44
Natividad E., Miguel Castro, Arturo Mediano
Adiabatic vs. non-adiabatic determination of specific absorption
rate of ferrofluids. Journal of Magnetism and Magnetic Materials
2009; 321: 1497-1500.
1.45
Zhang L., Yawei Xu, Hailiang Yao,
Liqi Xie, Jun Yao, Haojie Lu and Pengyuan Yang. Boronic Acid
Functionalized Core–Satellite Composite Nanoparticles for Advanced Enrichment of
Glycopeptides and Glycoproteins. Chem. Eur. J. 2009; 15: 10158–10166.
1.46
Lavilla M. Ruth De Luis, María Dolores
Pérez, Miguel Calvo, Lourdes Sánchez. Selection of high affine peptide
ligands for detection of ClostridiumTyrobutyricumspores. Journal of
Microbiological Methods 2009; 79: 214–219.
1.47
Guo Zhongxian, Ying Liu, Shuping Li
and Zhaoguang Yang. Interaction of bacteria and ionexchange particles
and its potential in separation for matrix-assisted laser desorption / ionization
mass spectrometric identification of bacteria in water. Rapid Commun.
Mass Spectrom. 2009; 23: 3983–3993.
1.48
Jaetao Jason E., Kimberly S. Butler,
Natalie L. Adolphi, Debbie M. Lovato, Howard C. Bryant, Ian Rabinowitz, Stuart
S. Winter, Trace E. Tessier, Helen J. Hathaway, Christian Bergemann, Edward R.
Flynn and Richard S. Larson. Enhanced Leukemia Cell Detection Using a
Novel Magnetic Needle and Nanoparticles. Cancer Res 2009; 69 (21):
8310–8316.
1.49
Pedersen M. B., Zhou X., Larsen E.K.U.,
Sørensen U. S., Kjems J., Nygaard J.V., Nyengaard J.R., Meyer R.L., Boesen T.
and Jensen. Curvature of Synthetic and Natural Surfaces Is an Important
Target Feature in Classical Pathway Complement Activation. The Journal
of Immunology 2010; 184: 1931-1945.
References - Detection
2.01
Hilger I., Hofmann F., Reichenbach J.R.,
Bergemann C., Hiergeist R., Andrä W., Hergt R., Kaiser W.A. In
vitro imaging of magnetite particles. RöFo 2001; Band: 173.
2.02
Lind K., Kresse M., Müller R. Comparison
of protein adsorption patterns onto differently charged hydrophilic
superparamagnetic iron oxide particles obtained in vitro and ex vivo.
Electrophoresis 2001; 22: 3514-3521.
2.03
Lind K., Kresse M., Debus N. P. and
Müller R. H. A Novel Formulation for Superparamagnetic
Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of
Physicochemical Properties and The in vivo Behaviour. J. Drug Targeting
2002; 10 (3): 221-230.
2.04
Eberbeck D., Bergemann C., Hartwig S.,
Steinhoff U. and Trahms L. Binding kinetics of magnetic
nanoparticles on latex beads studied by magnetorelaxometry. Appl.
Organometal. Chem. 2004; 18: 542-547.
2.05
Eberbeck D., Bergemann C., Hartwig S.,
Steinhoff U. and Trahms L. Binding kinetics of magnetic
nanoparticles on latex beads and yeast cells studied by
magnetorelaxometry. J. of Magnetism and Magnetic Materials 2005; 289:
435-438.
2.06
Flynn E. R. and Bryant H.C. A
biomagnetic system for in vivo cancer imaging. Phys. Med. Biol. 2005;
50: 1273-1293.
2.07
Häfeli Urs O., Lobedann M. A.,
Steingroewer J., Moore Lee R. and Riffled J. Optical
method for measurement of magnetophoretic mobility of individual
magnetic microspheres in defined magnetic field. Journal of Magnetism
and Magnetic Materials 2005; 293: 224–239.
2.08
Eberbeck D., Wiekhorst F., Steinhoff U.
and Trahms L. Aggregation behaviour of magnetic
nanoparticle suspensions investigated by magnetorelaxometry. J. Phys.:
Condens. Matter 2006; 18: 2829-2846.
2.09
Kettering M. et al. Magnetically
Based Enhancement of Nanoparticle Uptake in Tumor Cells: Combination of
Magnetically Induced Cell Labeling and Magnetic Heating. Fortschr.
Röntgenstr. 2006; 178: 1255-1260.
2.10
Bryant H.C., Sergatskov D.A., Lovato D.,
Adolphi N.L., Larson R.S. and Flynn E.R. Magnetic
needles and superparamagnetic cells. Phys. Med. Biol. 2007; 52:
4009-4025.
2.11
Flynn E.R., Bryant H.C., Bergemann Ch. et
al. Use of a SQUID array to detect T-cells with
magnetic nanoparticles in determining transplant rejection. J. Magnetism
Magnet. Materials 2007; 311: 429-435.
2.12
Ludwig F., Heim E. and Schilling M. Characterization
of superparamagnetic nanoparticles by analyzing the magnetization and
relaxation dynamics using fluxgate magnetometers. J. of Applied Physics
2007; 101: (113909) 1 – 10.
2.13
Kettering M., Winter J., Zeisberger M.,
Bremer-Streck S., Oehring H., Bergemann C., Alexiou C., Hergt R.,
Halbhuber J., Kaiser W. and Hilger I. Magnetic
nanoparticles as bimodal tools in magnetically induced labelling and
magnetic heating of tumour cells: an in vitro study. Nanotechnology
2007; 18: 175101 (9pp).
2.14
Eberbeck D., Bergemann C., Wiekhorst F.,
Steinhoff U. and Trahms L. Quantification of specific
bindings of biomolecules by magnetorelaxometry. J. of Nanobiotechnology
2008; 6: 4.
2.15
Öisjöen F., Magnelind P., Kalabukhov A.
and Winkler D. High-Tc SQUID gradiometer system for
immunoassays. Supercond. Sci. Technol. 2008; 21: 1-4.
2.16
Jia W., Xua G., Sclabassia R. J., Zhu
J-G, Bagic A., Suna M. Detection of magnetic
nanoparticles with magnetoencephalography J. of Magnetism and Magnetic
Materials 2008; 320: 1472–1478.
2.17
Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross
BD, Yang VC. Iron oxide nanoparticles as a drug delivery vehicle for MRI
monitored magnetic targeting of brain tumors. Biomaterials. 2008
Feb;29(4):487-96.
2.18
Gonzalez-Lara, Xiaoyun Xu, Klara
Hofstetrova, Anna Pniak, Arthur Brown and Paula J. Foster In
Vivo Magnetic Resonance Imaging of Spinal Cord Injury in the Mouse.
JOURNAL OF NEUROTRAUMA 2009; 26:753–762.
2.19
Adolphi N.L., Dale L. Huber, Jason E.
Jaetao, Howard C. Bryant, Debbie M. Lovato, Danielle L. Fegan, Eugene L.
Venturini, Todd C. Monson, Trace E. Tessier, Helen J. Hathaway,
Christian Bergemann, Richard S. Larson, Edward R. Flynn. Characterization
of magnetite nanoparticles for SQUID-relaxometry and magnetic needle
biopsy. Journal of Magnetism and Magnetic Materials 2009; 321:
1459–1464.
2.20
Heim E., Frank Ludwig, Meinhard Schilling Binding
assays with streptavidin-functionalized superparamagnetic nanoparticles and
biotinylated analytes using fluxgate magnetorelaxometry. J. of Magnetism
and Magnetic Materials 2009; 321: 1628-1631.
2.21
Ludwig F., Erik Heim, Meinhard Schilling Characterization
of magnetic core-shell nanoparticles by fluxgate magnetorelaxometry, ac susceptibility,
transmission electron microscopy and photon correlation spectroscopy-A comparative
study. J. of Magnetism and Magnetic Materials 2009; 321: 1644-1647.
2.22
Goodwill PW, Scott GC, Stang PP, Conolly SM. Narrowband
magnetic particle imaging. IEEE Trans Med Imaging. 2009;28(8):1231-1237.
2.23
Yusdy, Sohan R. Patel, Miranda G.S. Yapa,
Daniel I.C. Wanga. Immobilization of l-lactate dehydrogenase on magnetic nanoclusters for
chiral synthesis of pharmaceutical compounds. Biochemical Engineering Journal xxx (2009)
xxx–xxx. Article in press.
2.24
Richter H., Kettering M., Wiekhorst F., Steinhoff U.,
Hilger I.and Trahms T. Magnetorelaxometry for localization and quantification of
magnetic nanoparticles for thermal ablation studies. Phys.Med.Biol. 2010; 55: 623–633.
References - Magnetofection™
3.001
Plank C., Scherer F., Schillinger U.,
Anton M. Magnetofection: Enhancement and localization
of gene delivery with magnetic particles under influence of a magnetic
fields. J. Gene Med. 2000; 2((5) Suppl.): S24.
3.002
Scherer F., Anton M., Schillinger U.,
Henke J., Bergemann C., Krüger A., Gänsbacher B. and Plank C. Magnetofection:
enhancing and targeting gene delivery by magnetic force in vitro and in
vivo. Gene Therapy 2002; 9: 102-109.
3.003
Plank C., Schillinger U., Scherer F.,
Bergemann C., Remy J.-S., Krötz F., Anton M., Lausier J. and Rosenecker
J. The Magnetofection Method: Using Magnetic Force to
Enhance Gene Delivery. Biol. Chem. May 2003; 384: 737-747.
3.004
Plank C., Anton M., Rudolph C.,
Rosenecker J. and Krötz F. Enhancing and targeting
nucleic acid delivery by magnetic force. Expert Opinion on Biological
Therapy 2003; 3: 745-758.
3.005
Plank C., Scherer F., Schillinger U.,
Bergemann C., Anton M. Magnetofection: enhancing and
targeting gene delivery with superparamagnetic nanoparticles and
magnetic fields. J. Liposome Res. 2003; 13(1): 29-32.
3.006
Plank C. Magnetofection:
enhancing and targeting gene delivery with lipid-DNA vectors by magnetic
force. J. Liposome Res. 2003; 13(1): 105-106.
3.007
Krötz F., Son HY., Gloe T., Planck C. Magnetofection
Potentiates Gene Delivery to Cultured Endothelial. Journal of Vascular
Research 2003; 40: 425-434.
3.008
Krötz F., Wit C., Sohn HY., Zahler S.,
Gloe T., Pohl U. and Plank C. Magnetofection-A highly
efficient tool for antisense oligonucleotide delivery in vitro and in
vivo. Mol. Ther. May 2003; 7(5): 700-710.
3.009
Bridell H. Magnetic
field guided nucleic acid delivery to target the Raf-1 kinase in human
umbilical vein endothelial cells. Master thesis in medical science 2003,
Technical University of Munich, Germany.
3.010
Gersting S-W., Schillinger U., Lausier
J., Nicklaus P., Rudolph C., Plank C., Reinhardt D. and Rosenecker J. Gene
delivery to respiratory epithelial cells by magnetofection. J.Gene
Medicine 2004; 6: 913-922.
3.011
Griesenbach U., Duncan M. Geddes and Eric
W.F.W. Alton. Advances in cystic fibrosis gene therapy.
Current Opinion in Pulmonary Medicine 2004; 10: 542-546.
3.012
Huth S., Lausier J., Gersting S-W.,
Rudolph C., Plank C., Welsch U. and Rosenecker J. Insights
into the mechanism of magnetofection using PEI-based magnetofectins for
gene transfer. J.Gene Medicine 2004; 6: 923-936.
3.013
Rashmi K. Ambasta, Pravir Kumar et al. Direct
Interaction of the Novel Nox Proteins with p22phox Is required for the
Formation of a Functionally Active NADPH Oxidase. J. of Biological Chem.
2004; 279 (44): 45935-45941.
3.014
Weizhong W., XU Chunfang, WU Hua Use
of PEI-coated Magnetic Iron Oxide Nanoparticles as Gene Vectors Journal
of Huazhong University of Science and Technology (Med. Sci.) 2004; 24
(6): 618-620.
3.015
Basile J. R.,Talayeh Afkhami and J.
Silvio Gutkind. Semaphorin 4D/Plexin-B1 Induces
Endothelial Cell Migration through the Activation of PYK2, Src, and the
Phosphatidylinositol 3-Kinase-Akt Pathway. Molecular and Cellular
Biology 2005; 25 (16): 6889-6898.
3.016
Kadota S., Kanayama T., Miyajima N.,
Takeuchi K. And Nagata K. Enhancing of measles virus
infection by magnetofection. J. of Virol. Methods 2005; 128(1-2): 61-66.
3.017
Chudotvorova I., Ivanov A., Rama S.,
Hübner C.A., Pellegrino C., Ben-Ari Y. And Medina I. Early
expression of KCC2 in rat hippocampal cultures augments expression of
functional GABA synapses. J. Physiol. 2005; 566.3: 671-679.
3.018
Fransen M., Ilse Vastiau, Chantal Brees,
Vanessa Brys Guy P. Mannaerts and Paul P. Van Veldhoven. Analysis
of Human Pex19p's Domain Structure by Pentapeptide Scanning Mutagenesis.
J. Mol. Biol. 2005; 346: 1275-1286.
3.019
Goulimari P. et al. Gα12/13
Is Essential for Directed Cell Migration and Localized Rho-Dia1
Function. JBC 2005; 280 (51): 42242-42251.
3.020
Hollander K., Michal Bar-Chen, Shimon
Efrat. Baculovirus p35 increases pancreatic b-cell
resistance to apoptosis. Biochemical and Biophysical Research
Communications 2005; 332: 550-556.
3.021
Krötz F., Engelbrecht B., Buerkle MA.,
Bassermann F., Bridell H., Gloe T., Duyster J., Pohl U. and Sohn HY. The
tyrosine phosphatase, SHP-1, is a negative regulator of endothelial
superoxide formation. J. Am. Coll. Cardiol. 2005; 45(10): 1700-1706.
3.022
Recklies A.D., Hua Ling, Chantal White,
and Suzanne M. Bernier. Inflammatory Cytokines Induce
Production of CHI3L1 by articular Chondrocytes J. of Biol. Chem. 2005;
280 (50): 41213-41221.
3.023
Uchida Y. et al. Semaphorin3A
signalling is mediated via sequential Cdk5 and GSK3β
phosphorylation of CRMP2: implication of common phosphorylating
mechanism underlying axon guidance and Alzheimer's disease Genes to
Cells 2005; 10: 165-179.
3.024
Ulrike Schillinger et al. Advances
in magnetofection-magnetically guided nucleic acid delivery. Journal of
Magnetism and Magnetic Materials 2005; 293: 501-508.
3.025
Kumbrink J., Gerlinger M. and Johnson J.
P. Egr-1 Induces the Expression of Its Corepressor Nab2
by Activation of the Nab2 Promoter Thereby Establishing a Negative
Feedback Loop. JBC 2005; 280 (52): 42785-42793.
3.026
Liman J. et al. Interaction
of BAG1 and Hsp70 Mediates Neuroprotectivity and Increases Chaprone
Activity. Mol. and Cell. Biology 2005; 25 (9): 3715-3725.
3.027
Stadler S. C., Roman Polanetz, Stephan
Meier, Peter U. Mayerhofer, Johannes M. Herrmann, Katja Anslinger,
Adelbert A. Roscher, Wulf Röschinger, Andreas Holzinger Mitochondrial
targeting signals and mature peptides of 3-methylcrotonyl-CoA
carboxylase Biochemical and Biophysical Research Communications 2005;
334:939-946.
3.028
Basile J. R., Rogerio M. Castilho,
Vanessa P. Williams and J. Silvio Gutkind. Semaphorin
4D provides a link between axon guidance processes and tumor-induced
angiogenesis. PNAS 2006; 103 (24): 9017-9022.
3.029
Doshida M. et al. Raloxifene
Increases Proliferation and Up-regulates Telomerase Activity in Human
Umbilical Vein Endothelial Cells. The Journal of Biological Chemistry
2006; 281 (34): 24270-24278.
3.030
Kamau Sarah W. et al. Enhancement
of the efficiency of non-viral gene delivery by application of pulsed
magnetic field. Nucleic Acid Research 2006; 34 (5).
3.031
Kaneko M., Weiwen Yang, Yoshiki
Matsumoto, Fujiko Watt, Keiko Funa. Activity of a novel
PDGF β-receptor enhancer during the cell cycle and upon
differentiation of neuroblastoma. Experimental Cell Research 2006; 312:
2028-2039.
3.032
Kaur S. et al. Robo4
Signaling in Endothelial Cells Implies Attraction Guidance Mechanisms.
J. of Biol. Chem. 2006; 281 (16): 11347-11356.
3.033
Kim E-A., Yoon Tae Noh, Myung-Jeom Ryu,
Hyun-Taek Kim, Sung-Eun Lee, Cheol-Hee Kim, Cheolju Lee, Young Ho Kim
and Cheol Yong Choi. Phosphorylation and
Transactivation of Pax6 by Homeodomain-interacting Protein Kinase 2. J.
of Biolog. Chem. 2006; 281 (11): 7489-7497.
3.034
Nagata D., Takahashi M., Sawai K., Tagami
T., Usui T., Shimatsu A., Hirata Y., Naruse M. Molecular
Mechanism of the Inhibitory Effect of Aldosterone on Endothelial NO
Synthase Activity. Hypertension 2006; 48: 165-171.
3.035
Pasder O. et al. Downregulation
of Fer induces PP1 activation and cell-cycle arrest in malignant cells.
Oncogene 2006; 25: 4194-4206.
3.036
Pinto M.P., Grou C.P., Alencastre I.S.,
Oliveira M.E., Miranda C.S., Fransen M. and Azevedo J.E. The
Import Competence of a Peroxisomal Membrane Protein Is Determined by
Pex19p before the Docking Step. The J. of Biolog. Chem. 2006; 281(45):
34492-34502.
3.037
Romero D. G., Welsh B.L., Gomez-Sanchez
E.P., Yanes L.L., Rilli S. and Gomez-Sanchez C.E. Angiotensin
II-Mediated Protein Kinase D Activation Stimulates Aldosterone and
Cortisol Secretion in H295R Human Adrenocortical Cells. Endocrinology
2006; 147(12): 6046-6055.
3.038
Sapet C., Simoncini S., Loriod B.,
Puthier D., Sampol J., Nguyen C., Dignat-George F. and Anfosso F. Thrombin-induced
endothelial microparticle generation: identification of a novel pathway
involving ROCK-II activation by caspase-2. Blood 2006; 108: 1868-1876.
3.039
Seki T., Irie N., Nakamura K., Sakaue H.,
Ogawa W., Kasuga M., Yamamoto H., Ohmori S., Saito N. and Sakai N. Fused
protein of δPKC activation loop and PDK1-interacting fragment
(δAL-PIF) functions as a pseudosubstrate and an inhibitory molecule
for PDK1 when expressed in cells. Genes to Cells 2006; 11: 1051-1070.
3.040
Wang J., Zhang Y, Wei J., Zhang X., Zhang
B., Zhu Z., Zou W., Wang Y., Mou Z., Ni B. and Wu Y. Lewis
X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune
response. Immunology 2006; 121: 174-182.
3.041
Weizhong W., Xu C., Wu H. Magnetic
Iron Oxide Nanoparticles Mediated Gene Therapy for Breast Cancer - An In
Vitro Study. Journal of Huazhong University of Science and Technology
(Med. Sci.) 2006; 26 (6): 728-730.
3.042
Xenariou S. et al. Using
magnetic forces to enhance non-viral gene transfer to airway epithelium
in vivo. Gene Therapy 2006; 1-8.
3.043
McCAIG C et al. The Role
of Matrix Metalloproteinase-7 in Redefining the astric Microenvironment
in Response to Helicobacter pylori. Gastroenterology 2006;
130:1754-1763.
3.044
Minami R., Yamamoto M., Takahama S.,
Miyamura T., Watanabe H., Suematsu E. RCAS1 induced by
HIV-Tat is involved in the apoptosis of HIV-1 infected and uninfected
CD4+ T cells. Cellular Immunology 2006; 243: 41-47.
3.045
Mizutani C. et al. Mechanisms
of establishment of persistent SARS-CoV-infected cells. Biochemical and
Biophysical Research Communications 2006; 347: 261-265.
3.046
Mizutani C. et al. Inhibition
of cell proliferation by SARS-CoV infection in Vero E6 cells. FEMS
Immunol Med Microbiol 2006; 46: 236-243.
3.047
Mukai H.Y., Motohashi H., Ohneda O.,
Suzuki N., Nagano M. and Yamamoto M. Transgene
Insertion in Proximity to the c-myb Gene Disrupts
Erythroid-Megakaryocytic Lineage Bifurcation. Mol. and Cell. Biology
2006; 26 (21): 7953-7965.
3.048
Rubic T., Reinhard L. Lorenz Downregulated
CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic
mechanisms of interleukin-10. Cardiovascular Research 2006; 69: 527-535.
3.049
Kojima T., Ken-ichi Nakahama, Kiyotaka Yamamoto,
Hiroshi Uematsu and Ikuo Morita Age- and cell cycle-dependent changes in EPC-1/PEDF
promoter activity in human diploid fibroblast-like (HDF) cells. Molecular and
Cellular Biochemistry 2006; 293: 63-69.
3.050
Baer K., Bürli T., Huh K-H, Wiesner A.,
Erb-Vögtli S., Göckeritz-Dujmovic D., Moransard M., Nishimune A., Rees
M.I., Henley J.M., Fritschy J-M and Fuhrera C. PICK1
interacts with α7 neuronal nicotinic acetylcholine receptors and
controls their clustering. Mol. Cell. Neurosci. 2007; 35: 339-355.
3.051
Basile J.R., Holmbeck K., Bugge T.H. and
Gutkind J.S. MT1-MMP Controls Tumor-induced
Angiogenesis through the Release of Semaphorin 4D. J. of Biolog. Chem.
2007; 282 (9): 6899-6905.
3.052
Buerli T., Pellegrino C., Baer K.,
Lardi-Studler B., Chudotvorova I., Fritschy J-M., Medina I. and Fuhrer
C. Efficient transfection of DNA or shRNA vectors
intoneurons using Magnetofection NATURE PROTOCOLS 2007; 2(12):
3090-3101.
3.053
Couchoux H., Allard B., Legrand C.,
Jacquemond V. and Berthier C. Loss of caveolin-3
induced by the dystrophy-associated P104L mutation impairs L-type
calcium channel function in mouse skeletal muscle cells. J. of Physiol.
2007; 580.3: 745-754.
3.054
Deleuze V., Chalhoub E., El-Hajj R.,
Dohet C., Le Clech M., Couraud P-O., Philippe H. and Mathieu D. TAL-1/SCL
and Its Partners E47 and LMO2 Up-Regulate VE-Cadherin Expression in
Endothelial Cells. Mol. and Cell. Biology 2007; 27 (7): 2687-2697.
3.055
Eder P., D. Probst, C. Rosker, M.
Poteser, H. Wolinski, S.D. Kohlwein, C. Romanin, K. Groschner Phospholipase
C-dependent control of cardiac calcium homeostasis involves a TRPC3-NCX1
signaling complex. Cardiovascular Research 2007; 73: 111-119.
3.056
Fukushima T., Tezuka T., Shimomura T.,
Nakano S. and Kataoka H. Silencing of Insulin-like
Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both
Invasiveness and Expression of Progression-associated Gene CD24. J. of
Biolog. Chem. 2007; 282 (25): 18634-18644.
3.057
Jahnke A., Hirschberger J., Fischer C.,
Brill T., Köstlin R., Plank C., Küchenhoff H., Krieger S., Kamenica K.
and Schillinger U. Intra-tumoral Gene Delivery of
feIL-2, feIFN-c and feGM-CSF using Magnetofection as a Neoadjuvant
Treatment Option for Feline Fibrosarcomas: A Phase-I Study. J. Vet. Med.
A 2007; 54: 1-8.
3.058
Romero D.G., Yanes L.L., de Rodriguez
A.F., Plonczynski M.W., Welsh B.L., Reckelhoff J.F., Gomez-Sanchez E.P.
and Gomez-Sanchez C.E. Disabled-2 (Dab2) is Expressed
in Adrenal Zona Glomerulosa and is Involved in Aldosterone Secretion.
Endocrinology 2007, First published ahead of print February 15, 2007 as
doi:10.1210/en. 2006-1509.
3.059
Romero D.G., Rilli S., Plonczynski M.W.,
Yanes L.L., Zhou M.Y., Gomez-Sanchez E.P. and Gomez-Sanchez C.E. Adrenal
transcription regulatory genes modulated by angiotensin II and their
role in steroidogenesis. Physiol. Genomics 2007; 30: 26-34.
3.060
Sacha J.B., Chung C., Rakasz E.G.,
Spencer S.P., Jonas A.K., Bean A.T., Lee W., Burwitz B.J., Stephany
J.J., Loffredo J.T, Allison D.B., Adnan S., Hoji A., Wilson N.A.,
Friedrich T.C., Lifson J.D., Yang O.O. and Watkins D.I. Gag-Specific
CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus
Integration and Viral Protein Expression. The Journal of Immunology
2007; 178: 2746-2754.
3.061
Steele I.A., Rod Dimaline R., Pritchard
D.M., Peek Jr. R.M., Wang T.C., Dockray G.J. and Varro A. Helicobacter
and gastrin stimulate Reg1 expression in gastric epithelial cells
through distinct promoter elements. Am. J. Physiol. Gastrointest. Liver
Physiol. 2007; 293: G347-G354.
3.062
Schäfer C., Hoffmann L., Heldt K., Reza
M., Lornejad-Schäfer, Brauers G., Gehrmann T., Garrow T.A., Häussinger
D., Mayatepek E., Schwahn B.C. and Schliess F. Osmotic
regulation of betaine homocysteine-S-methyltransferase expression in
H4IIE rat hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol.
2007; 292:1089-1098.
3.063
Tan Z., X Sun, F-S Hou, H-W Oh, LGW
Hilgenberg, EM Hol, FW van Leeuwen, MA Smith, DK O'Dowd and SS Schreiber. Mutant
ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in
association with neuronal degeneration. Cell Death and Differentiation 2007;
14: 1721-1732.
3.064
Nakamura A., Yukiko Sakai, Chieri Ohata,
Toshi Komurasaki. Expression and significance of a disintegrin and metalloproteinase
with thrombospondin motifs (ADAMTS)-1 in an animal model of renal interstitial fibrosis
induced by unilateral ureteral obstruction. Experimental and Toxicologic
Pathology 2007; 59: 1-7.
3.065
McBain S.C., H. H. P. Yiu, A. El Haj and J.
Dobson. Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA
delivery and transfection. Journal of Materials Chemistry 2007; 17: 2561-2565.
3.066
Huang P., T Senga and M Hamaguchi. A novel
role of phospho-b-catenin in microtubule regrowth at centrosome. Oncogene 2007; 26:
4357-4371.
3.067
Hasegawa T., Toshiyuki Matsuzaki, Yuki Tajika,
Abduxukur Ablimit, Takeshi Suzuki, Takeo Aoki Haruo Hagiwara, Kuniaki Takata. Differential
localization of aquaporin-2 and glucose transporter 4 in polarized MDCK cells. Histochem
Cell Biol 2007; 127: 233-241.
3.068
Guix S., Miyuki Asanaka, Kazuhiko Katayama, Sue E.
Crawford, Frederick H. Neill, Robert L. Atmar, and Mary K. Estes. Norwalk Virus RNA Is
Infectious in Mammalian Cells. Journal of Virology 2007; 81(22): 12238-12248.
3.069
Varro A., Kenny S., Hemers E., McCaig C.,
Przemeck S., Wang T.C., Bodger K. and Pritchard D.M. Increased
gastric expression of MMP-7 in hypergastrinemia and significance for
epithelial-mesenchymal signalling. Am. J. Physiol. Gastrointest. Liver
Physiol. 2007; 292: G1133-G1140.
3.070
Lardi-Studler B., Smolinsky B., Petitjean
C.M., Koenig F., Sidler C., Meier J.C., Fritschyl J-M. and Schwarz G. Vertebrate-specific
sequences in the gephyrin E-domain regulate cytosolic aggregation and
postsynaptic clustering. Journal of Cell Science 2007; 120: 1371-1382.
3.071
Lartigue G., Dimaline R., Varro A. and
Dockray G.J. Cocaine- and Amphetamine-Regulated
Transcript: Stimulation of Expression in Rat Vagal Afferent Neurons by
Cholecystokinin and Suppression by Ghrelin. The Journal of Neuroscience
2007; 27(11): 2876 -2882.
3.072
Mykhaylyka O., Vlaskoua D., Tresilwised
N., Pithayanukul P, Möller W., Plank C. Magnetic
nanoparticle formulations for DNA and siRNA delivery. J.of Magnetism and
Magnetic Materials 2007; 311: 275-281.
3.073
Mykhaylyk O., Antequera Y.S., Vlaskou D.
& Plank Ch. Generation of magnetic nonviral gene
transfer agents and Magnetofection in vitro. Nature Protocols 2007;
2(10): 1-21.
3.074
Yim H-J., Kim H-J., Ko J-H., Cho Y-E.,
Kim S-M., Kim J-Y., Lee S. and Park J-H. The putative
tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death. Cell
Death and Differentiation 2007; 1-8.
3.075
Yim Ji-Hye, Yong-Jun Kim, Young-Eun Cho,
Jeong-Hun Ko, Su-Mi Kim, Jee-Youn Kim, Jae-Hoon Park. GLTSCR2
Sensitizes Cells to Hypoxic Injury without Involvement of Mitochondrial
Apoptotic Cascades Pathobiology 2007;74:301-308.
3.076
Yoon W. S., Won Cheol Choi, Jeong-Im Sin,
Yong Keun Park Antitumor therapeutic effects of
Salmonella typhimurium containing Flt3 Ligand expression plasmids in
melanoma-bearing mouse. Biotechnology Letters 2007; 29:511-516.
3.077
Thomas J.A., Ott D.E. and Gorelick R.J. Efficiency
of Human Immunodeficiency Virus Type 1 Postentry Infection Processes:
Evidence against Disproportionate Numbers of Defective Virions. Journal
of Virology 2007; 81 (8): 4367-4370.
3.078
Arnoux V., Mayssaa Nassour, Annie L'Helgoualc'h,
Robert A. Hipskind and Pierre Savagner. Erk5 Controls Slug Expression and Keratinocyte
Activation during Wound Healing. Molecular Biology of the Cell 2008; 19: 4738-4749.
3.079
Ashurst H.L., Andrea Varro and Rod Dimaline.
Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo.
Experimental Physiology 2008; 93.2: 223-236.
3.080
Bataille A.M., James Goldmeyer, and J. Larry Renfro.
Avian renal proximal tubule epithelium urate secretion is mediated by Mrp4. Am J
Physiol Regul Integr Comp Physiol 2008; 295: R2024-R2033.
3.081
Burdyga G., Guillaume de Lartigue, Helen E. Raybould,
Richard Morris, Rod Dimaline, Andrea Varro, David G. Thompson and Graham J. Dockray.
Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the
Stomach. The Journal of Neuroscience 2008; 28(45):11583-11592.
3.082
Cestéle S., Paolo Scalmani, Raffaella Rusconi, Benedetta
Terragni, Silvana Franceschetti and Massimo Mantegazza. Self-Limited Hyperexcitability:
Functional Effect of a Familial Hemiplegic Migraine Mutation of the Nav1.1 (SCN1A) Na+ Channel.
The Journal of Neuroscience 2008; 28(29): 7273-7283.
3.083
Dobson J., SC McBain, N Farrow, CD Batich. Oscillating
magnet arrays for enhanced magnetic nanoparticle-based gene transfection. European Cells and
Materials 2008; 16 Suppl. 3: (page 48).
3.084
Choi S. M., Cho H-J., Cho H., Kim K. H.,
Kim J. B. and Park H. Stra13/DEC1 and DEC2 inhibit
sterol regulatory element binding protein-1c in a hypoxia-inducible
factordependet mechanism. Nucleic Acids Research 2008; Published
October 5: 1-14.
3.085
Francois M., Andrea Caprini, Brett
Hosking, Fabrizio Orsenigo, Dagmar Wilhelm, Catherine Browne, Karri
Paavonen, Tara Karnezis, Ramin Shayan, Meredith Downes, Tara Davidson,
Desmond Tutt, Kathryn S. E. Cheah, Steven A. Stacker, George E. O.
Muscat, Marc G. Achen, Elisabetta Dejana & Peter Koopman. Sox18
induces development of the lymphatic vasculature in mice NATURE 2008;
456:643-648.
3.086
Guillaud L., Wong R. and Hirokawa N. Disruption
of KIF17-Mint1 interaction by CaMKIIdependent phosphorylation: a
molecular model of kinesin-cargo release. Nature Cell Biology 2008; 10
(1): 19-29.
3.087
Hüttinger C., Hirschberger J., Jahnke A.,
Köstlin R., Brill T., Plank C., Küchenhoff H., Krieger S. and
Schillinger U. Neoadjuvant gene delivery of feline
granulocyte-macrophage colony-stimulating factor using magnetofection
for the treatment of feline fibrosarcomas: a phase I trial. J. of Gene
Med. 2008; 10: 655-667.
3.088
Kim Y.-B., Suyong Choi, Moon-Chang Choi,
Min-A Oh, Sin-Ae Lee, Moonjae Choy, Kensaku Mizuno, Sung-Hoon Kim and
Jung Weon Lee. Cell Adhesion-dependent Cofilin Serine 3
Phosphorylation by the Integrin-linked Kinase c-Src Complex. J. of
Biolog. Chem. 2008; 283 (15): 10089-10096.
3.089
Kojima A., Ken-ichi Nakahama, Kyoko
Ohno-Matsui, Noriaki Shimada, Keisuke Mori, Sachiko Iseki, Tetsuji Sato, Manabu Mochizuki,
Ikuo Morita. Connexin 43 contributes to differentiation of retinal pigment epithelial
cells via cyclic AMP signalling. Biochemical and Biophysical Research Communications
2008; 366: 532-538.
3.090
Kuczewski N., Christophe Porcher, Nadine Ferrand,
Hervé Fiorentino, Christophe Pellegrino, Richard Kolarow, Volkmar Lessmann, Igor Medina and
Jean-Luc Gaiarsa. Backpropagating Action Potentials Trigger Dendritic Release of BDNF
during Spontaneous Network Activity. The Journal of Neuroscience 2008; 28(27): 7013-7023.
3.091
Lee C. H., Kim E. J., Jeon K., Tae J. C.,
Lee K. S., Kim Y. O., Jeong M.-Y., C.-W. Yun et. al. Simple,
Efficient, and Reproducible Gene Transfection of Mouse Embryonic Stem
Cells by Magnetofection. Stem Cells and Development 2008; 17:133-141.
3.092
Mannell H., Nicole Hellwig, Torsten Gloe, Christian
Plank, Hae-Young Sohn, Leopold Groesser, Barbara Walzog, Ulrich Pohl, Florian Krötz. Inhibition
of the Tyrosine Phosphatase SHP-2 Suppresses Angiogenesis in vitro and in vivo. Journal of
Vascular Research 2008; 45: 153-163.
3.093
Markova O., Marat Mukhtarov, Eleonore Real, Yves Jacob,
Piotr Bregestovski. Genetically encoded chloride indicator with improved sensitivity.
Journal of Neuroscience Methods 2008; 170: 67-76.
3.094
Matchkov V.V., Per Larsen, Elena V.
Bouzinova, Aleksandra Rojek, Donna M. Briggs Boedtkjer, Veronika
Golubinskaya, Finn Skou Pedersen, Christian Aalkjær and Holger Nilsson.
Bestrophin-3 (Vitelliform Macular Dystrophy 2-Like 3
Protein) Is Essential for the cGMP-Dependent Calcium-Activated Chloride
Conductance in Vascular Smooth Muscle Cells. Circ. Res.
2008;103: 864-872.
3.095
McBain S.C., U. Griesenbach, S. Xenariou, A. Keramane, C.D.
Batich, E.W.F.W. Alton and J. Dobson. Magnetic nanoparticles as gene delivery agents: enhanced
transfection in the presence of oscillating magnet arrays. Nanotechnology 2008; 19: 405102 (5pp).
3.096
Mukhtarov M., Markova O., Real E., Jacob Y., Buldakova S.,
Bregestovski P. Monitoring of chloride and activity of glycine receptor channels using genetically
encoded fluorescent sensors. Phil. Trans. R. Soc. A 2008; 366: 3445-3462.
3.097
Sbai O., Lotfi Ferhat, Anne Bernard, Yatma Gueye, Adlane
Ould-Yahoui, Sophie Thiolloy, Eliane Charrat, Gérard Charton, Evelyne Tremblay, Jean-Jacques Risso,
Jean-Paul Chauvin, Jean-Pierre Arsanto, Santiago Rivera, Michel Khrestchatisky. Vesicular
trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1
in neuronal cells. Molecular and Cellular Neuroscience 2008; 39: 549-568.
3.098
Ufer C., Chi Chiu Wang, Michael Fähling, Heike Schiebel, Bernd
J. Thiele, E. Ellen Billett, Hartmut Kuhn and Astrid Borchert. Translational regulation of
glutathione peroxidase 4 expression through guaninerich sequence-binding factor 1 is essential for embryonic
brain development. Genes & Development 2008; 22: 1838-1850.
3.099
Yamaguchi T., Yoshihisa Watanabe, Masaki Tanaka, Masanori Nakagawa
and Nozomi Yamaguchi. cAMP-Dependent Regulation of Spinesin/TMPRSS5 Gene Expression in
Astrocytes. Journal of Neuroscience Research 2008; 86: 610-617.
3.100
Yang Shieh-Yueh, Jui-Sheng Sun,
Cheng-Heng Liu, Yang-Hwei Tsuang, Li-Ting Chen, Chin-Yih Hong,
Hong-Chang Yang, and Herng-Er Horng. Ex Vivo
Magnetofection with Magnetic Nanoparticles: A Novel Platform for
Nonviral Tissue Engineering. Artif Organs 2008; 32 (3):195-204.
3.101
Han S.J., Duong H.-Q., Choi J. E., Lee T.-B., Kim C. H.,
Lee S. Y., Jeon H. M., Shin S.-H., Lim S.-C. and Kang H. S. Hyperthermia switches glucose
depletion-induced necrosis to apoptosis in A549 lung adenocarcinoma cells. INTERNATIONAL JOURNAL OF
ONCOLOGY 2008; 32: 851-860.
3.102
Cho Li-La, Young-Mee Moon, Yu-Jung Heo, Yun-JuWoo, Ji-Hyeon Ju,
Kyung-Su Park, Sung-Il Kim, Sung-Hwan Park, Ho-Youn Kim, Jun-Ki Min. NF-кB inhibition leads to
increased synthesis and secretion of MIF in human CD4+ T cells. Immunology Letters 2009; 123:
21-30.
3.103
Egaňa L.A., Rolando A. Cuevas, Tracy B. Baust, Leonardo A.
Parra, Rehana K. Leak, Sarah Hochendoner, Karina Peňa, Marisol Quiroz, Weimin C. Hong, Mario M. Dorostkar,
Roger Janz, Harald H. Sitte and Gonzalo E. Torres. Physical and Functional Interaction between the
Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3. The Journal of Neuroscience
2009; 29(14): 4592-4604.
3.104
Fiorentino H., Nicola Kuczewski, Diabe Diabira, Nadine
Ferrand, Menelas N. Pangalos, Christophe Porcher and Jean-Luc Gaiarsa. GABAB Receptor
Activation Triggers BDNF Release and Promotes the Maturation of GABAergic Synapses. The Journal of
Neuroscience 2009; 29(37): 11650-11661.
3.105
Ivanov A., Monique Esclapez, Christophe Pellegrino, Tomoaki
Shirao and Lotfi Ferhat. Drebrin A regulates dendritic spine plasticity and synaptic function in
mature cultured hippocampal neurons. Journal of Cell Science 2009; 122: 524-534.
3.106
Kenny S., Cedric Duval, Stephen J. Sammut, Islay Steele,
D. Mark Pritchard, John C.Atherton, Richard H. Argent, Rod Dimaline, Graham J. Dockray and Andrea Varro.
Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in
gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2009; Article in press.
3.107
Megias J., Maria Isabel Guillen, Victoria Clerigues,
Ana I. Rojo, Antonio Cuadrado, Miguel Angel Castejon, Francisco Gomar, Maria Jose Alcaraz.
Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and
prostaglandin E2 production in osteoarthritic chondrocytes. Biochemical Pharmacology 2009;
77: 1806-1813.
3.108
Tanaka M., Yoshihisa Watanabe and Kanji Yoshimoto.
Regulation of Relaxin 3 Gene Expression Via cAMP-PKA in a Neuroblastoma Cell Line.
Journal of Neuroscience Research 2009; 87: 820-829.
3.109
Svingen T., Wilhelm D., Combes A. N.,
Hosking B., Harley V. R., Sinclair A. H. and Koopman P. Ex
Vivo Magnetofection: A Novel Strategy for the Study of Gene Function in
Mouse Organogenesis. DEVELOPMENTAL DYNAMICS 2009; 238:956-964.
3.110
Vieyres G., Allan G.N. Angus, Anita
Haberstroh, Thomas F. Baumert, Jean Dubuisson, Arvind H. Patel Rapid
synchronization of hepatitis C virus infection by magnetic adsorption
Journal of Virological Methods 2009; 157: 69-79.
3.111
Wong J. and Cynthia Shannon Weickert Transcriptional
Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests
Convergence in Gene Susceptibility Pathways in Schizophrenia THE JOURNAL
OF BIOLOGICAL CHEMISTRY 2009; 284(28):18824-18832
3.112
Yiu H.P., Stuart C. McBain, Zoe A. D. Lethbridge, Martin R.
Lees, Jon Dobson. Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48
nanocomposite particles as a novel agent for magnet-assisted transfection. Journal of Biomedical
Materials Research Part A 2009; 386-392.
3.113
Hofmann A., Wenzel D., Becher U.M.,
Freitag D.F., Klein A. M., Eberbeck D., Schulte M., Zimmermann K.,
Bergemann C., Gleich B., Roell W., Weyh T., Trahms L., Nickenig G.,
Fleischmann B. K. and Pfeifer A. Combined targeting of
lentiviral vectors and positioning of transduced cells by magnetic
nanoparticles. PNAS 2009; 106 (1): 44-49.
3.114
Hofmann et al. Supporting
Information. 10.1073/pnas.0803746106, PNAS 2009: 1-9
3.115
Saeki Yuko, Takaho Endo, Kaori Ide, Takeshi Nagashima, Noriko
Yumoto, Tetsuro Toyoda, Harukazu Suzuki, Yoshihide Hayashizaki, Yoshiyuki Sakaki and Mariko Okada-Hatakeyama.
Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7
cells. BMC Genomics 2009; 10: 545.
References - Magnetic Drug Targeting
4.01
Lübbe A.S., Bergemann C. et al. Preclinical
Experiences with Magnetic Drug Targeting: Tolerance and Efficacy. Cancer
Research 1996; 56: 4694-4701.
4.02
Lübbe A.S. and Bergemann C. Selected
Preclinical and First Clinical Experiences with Magnetically Targeted
4'-Epidoxorubicin in Patients with Advanced Solid Tumors. In: Häfeli et
al. (Eds.), Scientific and Clinical Applications of Magnetic Carriers,
Plenum Press, New York, 1997.
4.03
Lübbe A.S., Bergemann C. et al. Clinical
Experiences with Magnetic Drug Targeting: A Phase I Study with
4'-Epidoxorubicin in 14 Patiens with Advanced Solid Tumors. Cancer
Research 1996; 56: 4686-4693.
4.04
Lübbe A.S. and Bergemann C. Editorial
Magnetically-controlled drug targeting. The Cancer J. 1998; 11: n° 3.
4.05
Lübbe A.S., Bergemann C., Brock J.,
McClure D.G. Physiological aspects in magnetic drug
targeting. J. of Magnetism and Magnetic Materials 1999; 194: 149-155.
4.06
Lübbe A.S., Bergemann C. and Alexiou C. Magnetically-controlled
Drug Targeting for cancer treatment. Recent Res. Devel. Cancer 2000; 2:
183-191.
4.07
Alexiou C., Arnold W., Klein R.J., Parak
F.G., Hulin P., Bergemann C., Erhardt W., Wagenpfeil S., Lübbe A.S. Locoregional
Cancer Treatment with Magnetic Drug Targeting. Cancer Research 2000; 60:
6641-6648.
4.08
Alexiou C., Arnold W., Hulin P., Klein
R.J., Renz H., Parak F.G., Bergemann C., Lübbe A.S. Magnetic
mitoxantrone nanoparticle detection by histology, X-ray and MRI after
magnetic tumor targeting. J. of Magnetism and Magnetic Materials 2001;
225: 187-193.
4.09
Alexiou C., Arnold W., Hulin P., Klein
R., Schmidt A., Bergemann C., Parak F.G. Therapeutic
Efficacy of Ferrofluid Bound Anticancer Agent. Magnetohydrodynamics
2001; 37: 318-322.
4.10
Babincova M., Babinec P. and Bergemann C.
High-Gradient Magnetic Capture of Ferrofluids:
Implications for Drug Targeting and Tumor Embolization. Z. Naturforsch.
2001; 56c: 909-911.
4.11
Hilger I., Andrä W., Hiergeist R., Hergt
R., Schubert H., Kaiser W. A. Electromagnetic Heating
of Breast Tumors in Interventional Radiology: In Vitro and in Vivo
Studies in Human Cadavers and Mice. Radiology 2001; 218: 570-575.
4.12
Lübbe A.S., M.D., Ph.D., Alexiou C. and
Bergemann C. Clinical Applications of Magnetic Drug
Targeting. J. of Surgical Res. 2001; 95: 200-206.
4.13
Lübbe A.S., Bergemann C. and Alexiou C. Targeting
Tumors with Magnetic Drugs, in: M. Pagé (Eds.), Cancer Drug Discovery
and Development: Tumor Targeting in Cancer Therapy. Humana Press Inc.
Totowa, New York, 2002.
4.14
Hilger I., Frühauf K., Andrä W.,
Hiergeist R., Hergt R., Kaiser W. A. Heating Potential
of Iron Oxides for Therapeutic Purposes in Interventional Radiology.
Acad Radiol 2002; 9: 198-202.
4.15
Flores G. A. & Liu J. In-vitro
Blockage of a Simulated Vascular System Using Magnetorheological Fluids
as a Cancer Therapy. European Cells and Materials 2002; 3(2): 9-11.
4.16
Alexiou C., Schmid R., Jurgons R.,
Bergemann C., Arnold W., Parak F.G. Targeting Tumor
Therapy with Magnetic Drug Targeting: Therapeutic Efficacy of Ferrofluid
Bound Mitoxantrone, in: S. Odenbach (Eds.), Ferrofluids: Magnetically
Controllable Fluids and Their Applications. Springer Verlag, Berlin,
2002.
4.17
Alexiou C., Schmidt A., Klein R., Hulin
P., Bergemann C., Arnold W. Magnetic drug targeting:
biodistribution and dependency om magnetic field strength. J. of
Magnetism and Magnetic Materials 2002; 252: 363-366.
4.18
Alexiou C., Jurgons R., Schmid R. J.,
Bergemann C., Henke J., Erhardt W., Huenges E. and Parak F. Magnetic
Drug Targeting-Biodistribution of the Magnetic Carrier and the
Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment.
J. Drug Targeting 2003; 11(3): 139-149.
4.19
Babincova M., Altanerova V., Altaner C.,
Cicmanec P. and Babinec P. In vivo heating of magnetic
nanoparticles in alternating magnetic field. Med. Phys. 2004; 31 (8):
2219-2221.
4.20
Lemke A.-J., Senfft von Pilsach M.-I.,
Lübbe A., Bergemann C. et al. MRI after magnetic drug
targeting in patients with advanced solid malignant tumors. Eur.
Radiology 2004; 14: 1949-1955.
4.21
Alexiou C., Jurgons R., Schmid R.,
Hilpert A., Bergemann C., Parak F. and Iro H. In vitro
and in vivo investigations of targeted chemotherapy with magnetic
nanoparticles. J. of Magnetism and Magnetic Materials 2005; 293:
389-393.
4.22
Alexiou C. et al. Targeting
cancer cells: magnetic nanoparticles as drug carriers. Eur. Biophys J.
2006; 35: 446-450.
4.23
Steinfeld U., Pauli Ch., Kaltz N.,
Bergemann Ch. and Lee Hyeck-Hee. T-lymphocytes as
potential therapeutic drug carrier for cancer treatment. Int. J. of
Pharmaceutics 2006; 311: 229-236.
4.24
Alexiou Ch., Dirk Diehl, Peter Henninger, Heinrich Iro,
Rudolf Röckelein, Wolfgang Schmidt and Horst Weber. A High Field
Gradient Magnet for Magnetic Drug Targeting. IEEE TRANSACTIONS ON
APPLIED SUPERCONDUCTIVITY 2006; 16(2): 1527-1530.
4.25
Shapiro B., Probst R., Potts H.E., Diver
D.A. and Lübbe A.S. Control to Concentrate Drug-Coated
Magnetic Particles to Deep-Tissue Tumors for Targeted Cancer
Chemotherapy. in press 2007
4.26
Dandamudi S. and Campbell R.B. The
drug loading, cytotoxicity and tumor vascular targeting characteristics
of magnetite in magnetic drug targeting. Biomaterials 2007; 28 (31):
4673-4683.
4.27
Dames P., Gleich B., Flemmer A., Hajek
K., Seidl N., Wiekhorst F., Eberbeck D., Bittmann I., Bergemann Ch.,
Weyh T., Trahms L., Rosenecker J. and Rudolph C. Targeted
delivery of magnetic aerosol droplets to the lung. Nature Nanotechnology
August 2007; 2 (8): 495-499.
4.28
Chertok B., Allan E. David, Yongzhuo
Huang and Victor C. Yang. Glioma Selectivity of
Magnetically Targeted Nanoparticles: A Role of Abnormal Tumor
Hydrodynamics. J Control Release. 2007 October 8; 122(3): 315–323.
4.29
Babincova M., Altanerova V., Altaner C.,
Bergemann C. and Babinec P. In Vitro Analysis of
Cisplatin Functionalized Magnetic Nanoparticles in Combined Cancer
Chemotherapy and Electromagnetic Hyperthermia. IEEE Transactions on
Nanobioscience, 2008; 7(1): 15-19.
4.30
McGill S. L., Carla L. Cuylear, Natalie L. Adolphi, Marek
Osinski and Hugh D. C. Smyth Magnetically Responsive Nanoparticles for Drug
Delivery Applications Using Low Magnetic Field Strengths IEEE Transactions
on Biosciences March 2009; 8 (1): 33 – 42.
4.31
Kallumadil M., Masaru Tada, Takashi Nakagawa, Masanori Abe,
Paul Southern, Quentin A. Pankhurst Suitability of commercial colloids for
magnetic hyperthermia. Journal of Magnetism and Magnetic Materials 2009;
321: 1509-1513.
4.32
Kettering M., Heike Zorn, Sibylle Bremer-Streck, Hartmut
Oehring, Matthias Zeisberger, Christian Bergemann, Rudolf Hergt, Karl-Jürgen
Halbhuber, Werner A Kaiser and Ingrid Hilger Characterization of iron oxide
nanoparticles adsorbed with cisplatin for biomedical applications. Phys.
Med. Biol. 2009; 54: 5109-5121.
4.33
Wiegand S., Thomas Heinen, Annette Ramaswamy, Andreas M.
Sesterhenn, Christian Bergemann, Jochen A. Werner, Andreas S. Lübbe
Evaluation of the tolerance and distribution of intravenously applied
ferrofluid particles of 250 and 500 nm size in an animal model. Journal
of Drug Targeting 2009;17(3): page 1.
4.34
Chertok B., Allan E. David, Bradford A. Moffat, Victor C.
Yang. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide
nanocarriers via adsorptive surface masking. Biomaterials 2009; XXX: 1–8. in press.
